Abstract: This article proposes a novel data-driven distributed recurrent neural network (DDD-RNN) based on neurodynamics principles to address the challenge of precise collaborative motion generation ...
AstraZeneca is pushing its small molecule GLP-1 drug to Phase 3 development for weight control, diabetes and other cardiometabolic conditions despite the asset failing to best one from Structure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results